13. Figure S12 . PA signal from 9 across a single slice of the mouse abdomen showing liver before and after injection up to 24 h.
13. Figure S12 . PA signal from 9 across a single slice of the mouse abdomen showing liver before and after injection up to 24 h.
14. Figure S13 . a) Enlarged images of the tumors at various time point with the PA intensities normalized (top).
Fold change in PA intensity in the tumor over that at t=0 in the tumor (bottom). b) Tumor-to-muscle ratio of PA amplitude at various time points up till 24 h.
15. Figure S14 . ICP-MS analysis of the percentage retention of injected dose (% ID) of 9 per organs, 24 h after injection. Error bars represent standard error of the mean, n = 3.
16. Figure S15 . Histopathology (H & E staining) of kidneys, heart and lungs tissues of mice, 24 h and 96 h after intravenous injection of 9, with that of control samples.
17. Figure S16 . Percentage weight change of control mice and mice injected with 9 up till 24 h and 96 h with respect to initial weight. Error bars represent standard error of the mean, n = 3 for samples with 9 and n = 2 for control samples.
18. Figure S17 . IR spectrum ( CO ) of 1 in DCM.
19. Figure S18 . IR spectrum ( CO ) of cluster 2 in hexane.
20. Figure S19 . IR spectrum ( CO ) of cluster 3 in DCM.
21. Figure S20 . IR spectrum ( CO ) of cluster 4 in DCM.
22. Figure S21 . IR spectrum ( CO ) of cluster 5 in DCM.
23. Figure S22 . IR spectrum ( CO ) of cluster 6 in DCM.
24. Figure S23 . IR spectrum ( CO ) of cluster 7 in DCM.
25. Figure S24 . IR spectrum ( CO ) of cluster 8 in DCM.
26. Figure S25 . IR spectrum ( CO ) of cluster 9 in acetonitrile.
27. Figure S26 . HRMS-ESI spectrum of cluster 9 with the calculated isotopic pattern.
28. Table S1 . ICP-MS analysis of Os content in various organs 24 h after injection of 9.
29. Table S2 . ICP-MS analysis of Os content in various organs organs 96 h after injection of 9.
30. Table S3 . ICP-MS analysis of background Os content in various organs in control animals (without the introduction of 9).
31. Table S4 . Calculation of the percentage retention of injected dose (% ID) of 9 in various organ tissues 24 h after injection of 9.
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Experimental section a. General methods
All reactions and manipulations were carried out under an argon atmosphere using standard Schlenk techniques. Solvents that were used for reaction were distilled over the appropriate drying agents under argon before use. Purification of compounds was generally carried out by column chromatography on silica gel, or by preparative thin-layer chromatography (TLC) using 20 cm x 20 cm plates pre-coated with silica gel 60 F 254 Infrared (IR) spectra were recorded on a Bruker Alpha FT-IR spectrometer. Solution spectra were recorded in DCM solution, unless otherwise stated, in a solution IR cell with NaCl windows and a path length of 0.1 mm, at a resolution of 2 cm -1 . Alternatively, IR spectra of aqueous samples were recorded by drop casting the mixture (10 μL) onto a CaF 2 disc, followed by drying under a stream of nitrogen before recording on the spectrometer. Optical absorption spectra were recorded using a Hitachi U-2900 double-beam spectrophotometer using quartz cuvette with path length of 10 mm. For samples of smaller volume (100 μL), the optical absorption spectra were recorded using a Beckman Coulter DU 730 spectrometer. HRMS were recorded in ESI mode on a Waters UPLC-Q-Tof MS mass spectrometer.
Compounds 1-8 were synthesized according to reported methods with slight modifications.
1-7
Os 3 (CO) 12 and Ru 3 (CO) 12 were purchased from Oxkem Ltd. [(Ph 3 P) 2 N]Cl and indocyanine green (ICG) were purchased from Sigma Aldrich. All other chemical reagents were purchased from other commercial sources and used without further purification.
b. Synthesis of cluster 9
The synthesis was adapted from the microwave-assisted synthesis of cluster 8. were seeded in wells within 96-well plate in growth medium at the same initial density of 10 000 cells per well, and allowed to adhere and grow for 24 h. They were serum-starved in serum-free DMEM for 24 h, followed by treatment with the indicated concentrations of compounds in serum-free DMEM (1 % DMSO) for 24 h. Control cells were treated with vehicle (1 % DMSO).
To each well, 10 μL of MTS reagent (MTS Cell Proliferation Assay Kit, BioVision, CA) was added and then left to incubate in a 37 °C incubator with 5% CO 2 for 2 h. The absorbance intensities at 490 nm were then measured and the cell proliferation relative to the control sample was calculated. Each sample was analyzed in triplicates and was corrected with background intensities from same incubation conditions without the cells. IC 50 was determined from three separate experiments and the mean value calculated.
d. Gel electrophoresis
Agarose gel (1%, UltraPure TM Agarose, Invitrogen) was cast with and immersed in 0.5 x TAE (Tris-acetate-EDTA buffer, prepared from 50 x stock solution, pH 8.0, 1 st BASE). Cluster 9 incubated in 10% DMSO in modified DMEM (30 L) for different duration (10 min, 1, 3, 5 and 7 days) was loaded into the respective wells of the gel and electrophoresed in a horizontal electrophoresis system (Wide Mini-sub® cell GT Basic System, Biorad, electrode spacing of 15 cm) at 150 V for 30 min.
e. Multispectral optoacoustic tomography (MSOT) experimental parameters and protocol
All phantom and in vivo mouse imaging experiments were performed using a real-time MSOT imaging system; inVision 128 (ithera Medical GmbH, Germany). 
f. Evaluation of PA activity of clusters 4-9 in phantom model
The phantom is made of polyurethane and is cylindrical in shape with a diameter of 2 cm, which is specially designed to mimic the shape, size, and optical properties of the mouse. In addition, it has two inner cylindrical channels, each with an inner diameter of 3 mm, one for holding the control medium and the other for holding the dissolved contrast agent in the same medium. The control medium and contrast agent suspension (170 μL each) were pipetted into the respective channels of the phantom, and placed in the MSOT imaging chamber using a phantom holder. For data acquisition, we set up an ROI of multiple transverse slices with a step size of 1 mm across the channel portion which contained the probe and control, applied excitation wavelengths from 680 to 900 nm with an interval of 10 nm for each transverse slice, and recorded the averaged PA signals from 10 frames for each wavelength and position. The acquired images were reconstructed using model based approach and PA signals were quantified using ViewMSOT at the respective  max of each probe from the reconstructed images. 9 The PA amplitude of the probe was determined by subtracting the values of the channel containing the control from that of the probe, and the mean was calculated from 10 different transverse slices. 
h. Image processing and analysis for in vivo experiments
Images acquired from the in vivo experiments were reconstructed using direct back projection approach for offline analysis. After image reconstruction, spectral unmixing was performed to resolve individual components from different chromophores in the system. For each pixel, the method fits the total measured optoacoustic spectrum to the known absorption spectra of the individual chromophores, based on least-squares linear regression. Images were exported out from ViewMSOT and further analyzed using Fiji (version 2.0.0), an open source imageprocessing package. 10 Regions of Interest (ROIs) were chosen from liver, spleen, kidney and tumor and quantified for multispectrally unmixed PA signals before and after probe injection. PA signals at all time-points were normalized against that of the pre-injection scan and expressed as fold change over the same. 
j. Histopathology of organ tissues of mice
Six mice were intravenously injected with cluster 9 (200 L, 500 M, 10% DMSO in saline) and euthanized after 24 h and 96 h (three mice at each time point) respectively. For the control sample, four mice were injected with 10% DMSO in saline instead. The mice were anaesthetized using ketamine (150 mg/mL) and xylazine (10 mg/kg) and euthanized by cervical dislocation to collect various organs for histopathology analysis. All organs were immediately fixed in 10% neutral buffered formalin (Sigma) and submitted to the Advanced Molecular Pathology Laboratory (AMPL), IMCB for histopathology evaluation. The pathology report was prepared by an experienced pathologist. All bright field images were captured using the Nikon
Ni-E upright microscope, with Plan Apo 20x DIC M N2 objective and Nikon DS-Ri2 camera.
The images were viewed using NIS-Elements software. 
